EIF2S2 and colorectal carcinoma: The expression rate of EIF2S2 in CRC patients was significantly positively correlated with SUVmax, SUVmean, and TLG (Figure 4C-E; P < 0.01), but not with MTV (Fig. 4F, P >0.05).